161 related articles for article (PubMed ID: 34600594)
1. Reduced receptor for advanced glycation end products is associated with α-SMA expression in patients with idiopathic pulmonary fibrosis and mice.
Baek H; Jang S; Park J; Jang J; Lee J; Hong SH; Kim WJ; Park SM; Yang SR
Lab Anim Res; 2021 Oct; 37(1):28. PubMed ID: 34600594
[TBL] [Abstract][Full Text] [Related]
2. Necrostatin-1 Alleviates Bleomycin-Induced Pulmonary Fibrosis and Extracellular Matrix Expression in Interstitial Pulmonary Fibrosis.
Mou F; Mou C
Med Sci Monit; 2020 Feb; 26():e919739. PubMed ID: 32019905
[TBL] [Abstract][Full Text] [Related]
3. Pulmonary delivery of a recombinant RAGE antagonist peptide derived from high-mobility group box-1 in a bleomycin-induced pulmonary fibrosis animal model.
Piao C; Zhuang C; Ko MK; Hwang DW; Lee M
J Drug Target; 2022 Aug; 30(7):792-799. PubMed ID: 35451894
[TBL] [Abstract][Full Text] [Related]
4. Advanced glycation end-products and receptor for advanced glycation end-products expression in patients with idiopathic pulmonary fibrosis and NSIP.
Kyung SY; Byun KH; Yoon JY; Kim YJ; Lee SP; Park JW; Lee BH; Park JS; Jang AS; Park CS; Jeong SH
Int J Clin Exp Pathol; 2014; 7(1):221-8. PubMed ID: 24427342
[TBL] [Abstract][Full Text] [Related]
5. Sulforaphane attenuates pulmonary fibrosis by inhibiting the epithelial-mesenchymal transition.
Kyung SY; Kim DY; Yoon JY; Son ES; Kim YJ; Park JW; Jeong SH
BMC Pharmacol Toxicol; 2018 Apr; 19(1):13. PubMed ID: 29609658
[TBL] [Abstract][Full Text] [Related]
6. Increased AGE-RAGE ratio in idiopathic pulmonary fibrosis.
Machahua C; Montes-Worboys A; Llatjos R; Escobar I; Dorca J; Molina-Molina M; Vicens-Zygmunt V
Respir Res; 2016 Nov; 17(1):144. PubMed ID: 27816054
[TBL] [Abstract][Full Text] [Related]
7. A role for the receptor for advanced glycation end products in idiopathic pulmonary fibrosis.
Englert JM; Hanford LE; Kaminski N; Tobolewski JM; Tan RJ; Fattman CL; Ramsgaard L; Richards TJ; Loutaev I; Nawroth PP; Kasper M; Bierhaus A; Oury TD
Am J Pathol; 2008 Mar; 172(3):583-91. PubMed ID: 18245812
[TBL] [Abstract][Full Text] [Related]
8. Antifibrotic properties of receptor for advanced glycation end products in idiopathic pulmonary fibrosis.
Ding H; Ji X; Chen R; Ma T; Tang Z; Fen Y; Cai H
Pulm Pharmacol Ther; 2015 Dec; 35():34-41. PubMed ID: 26545872
[TBL] [Abstract][Full Text] [Related]
9. Association of the RAGE/RAGE-ligand axis with interstitial lung disease and its acute exacerbation.
Yamaguchi K; Iwamoto H; Sakamoto S; Horimasu Y; Masuda T; Miyamoto S; Nakashima T; Fujitaka K; Hamada H; Hattori N
Respir Investig; 2022 Jul; 60(4):531-542. PubMed ID: 35504814
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of YAP1-gene Knockdown to Inhibit Alveolar-Epithelial-Cell Senescence and Alleviate Idiopathic Pulmonary Fibrosis (IPF).
Xu W; Song W; Wang YU; Zan Y; Zhang M; Li M; Huang Q; Zhao W; Sun YU; Hoffman RM; Wu J
Cancer Genomics Proteomics; 2021; 18(3 Suppl):451-459. PubMed ID: 33994367
[TBL] [Abstract][Full Text] [Related]
11. Paradoxical function for the receptor for advanced glycation end products in mouse models of pulmonary fibrosis.
Englert JM; Kliment CR; Ramsgaard L; Milutinovic PS; Crum L; Tobolewski JM; Oury TD
Int J Clin Exp Pathol; 2011 Mar; 4(3):241-54. PubMed ID: 21487520
[TBL] [Abstract][Full Text] [Related]
12. Glucagon like peptide-1 attenuates bleomycin-induced pulmonary fibrosis, involving the inactivation of NF-κB in mice.
Gou S; Zhu T; Wang W; Xiao M; Wang XC; Chen ZH
Int Immunopharmacol; 2014 Oct; 22(2):498-504. PubMed ID: 25111852
[TBL] [Abstract][Full Text] [Related]
13. FGF10 Therapeutic Administration Promotes Mobilization of Injury-Activated Alveolar Progenitors in a Mouse Fibrosis Model.
Lv YQ; Cai GF; Zeng PP; Dhlamini Q; Chen LF; Chen JJ; Lyu HD; Mossahebi-Mohammadi M; Ahmadvand N; Bellusci S; Li X; Chen C; Zhang JS
Cells; 2022 Aug; 11(15):. PubMed ID: 35954241
[TBL] [Abstract][Full Text] [Related]
14. The role of the receptor for advanced glycation end-products in lung fibrosis.
He M; Kubo H; Ishizawa K; Hegab AE; Yamamoto Y; Yamamoto H; Yamaya M
Am J Physiol Lung Cell Mol Physiol; 2007 Dec; 293(6):L1427-36. PubMed ID: 17951314
[TBL] [Abstract][Full Text] [Related]
15. Saikosaponin-d regulates angiogenesis in idiopathic pulmonary fibrosis through angiopoietin/Tie-2 pathway.
Wu Y; Zhang J; Wang X; Xu Y; Zheng J
Acta Histochem; 2023 Dec; 125(8):152100. PubMed ID: 37837833
[TBL] [Abstract][Full Text] [Related]
16. Proteomic studies on receptor for advanced glycation end product variants in idiopathic pulmonary fibrosis and chronic obstructive pulmonary disease.
Ohlmeier S; Mazur W; Salmenkivi K; Myllärniemi M; Bergmann U; Kinnula VL
Proteomics Clin Appl; 2010 Jan; 4(1):97-105. PubMed ID: 21137019
[TBL] [Abstract][Full Text] [Related]
17. TREM2 Insufficiency Protects against Pulmonary Fibrosis by Inhibiting M2 Macrophage Polarization.
Luo Q; Deng D; Li Y; Shi H; Zhao J; Qian Q; Wang W; Cai J; Yu W; Liu J
Int Immunopharmacol; 2023 May; 118():110070. PubMed ID: 37003186
[TBL] [Abstract][Full Text] [Related]
18. GHK Peptide Inhibits Bleomycin-Induced Pulmonary Fibrosis in Mice by Suppressing TGFβ1/Smad-Mediated Epithelial-to-Mesenchymal Transition.
Zhou XM; Wang GL; Wang XB; Liu L; Zhang Q; Yin Y; Wang QY; Kang J; Hou G
Front Pharmacol; 2017; 8():904. PubMed ID: 29311918
[No Abstract] [Full Text] [Related]
19. Indirubin alleviates bleomycin-induced pulmonary fibrosis in mice by suppressing fibroblast to myofibroblast differentiation.
Wang Q; Yu J; Hu Y; Chen X; Zhang L; Pan T; Miao K; Mou Y; Xu Y; Xiong W; Wang Y
Biomed Pharmacother; 2020 Nov; 131():110715. PubMed ID: 32927253
[TBL] [Abstract][Full Text] [Related]
20. Fluorofenidone attenuates pulmonary inflammation and fibrosis via inhibiting the activation of NALP3 inflammasome and IL-1β/IL-1R1/MyD88/NF-κB pathway.
Song C; He L; Zhang J; Ma H; Yuan X; Hu G; Tao L; Zhang J; Meng J
J Cell Mol Med; 2016 Nov; 20(11):2064-2077. PubMed ID: 27306439
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
